Bjork Elisabeth
- SEC CIK
- 0001810406
In the past year, 1 open-market purchase filing worth $34.4K and 2 sale filings worth $2.28M.
Current role at each company
- PHVS Pharvaris N.V.Directoras of Sep 21, 2026
- RCKT Rocket Pharmaceuticals, Inc.Directoras of Jan 6, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $34.4K
- 1 filing
- Sold
- $2.28M
- 2 filings
- Net
- −$2.25M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Bjork Elisabeth as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PHVS Pharvaris N.V.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 22, 2026 (view filing) | May 20 | 2 days | Bjork ElisabethDirector | SSale | −10.0K | $29.32 | −$293.2K | −39.7%15.2K after | 10b5-1 |
| Sep 21, 2026 (view filing)3:20 PM ET | Sep 17 | 4 days | Bjork ElisabethDirector | SSale | −52.5K | $37.89 | −$1.99M | −77.6%15.2K after |
RCKT Rocket Pharmaceuticals, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2025 (view filing) | Aug 27 | Same day | Bjork ElisabethDirector | PPurchase | +10.0K | $3.41 | +$34.1K | +33.3%40.0K after | |
| Jan 6, 2026 (view filing) | Jan 2 | 4 days | Bjork ElisabethDirector | PPurchase | +10.0K | $3.44 | +$34.4K | +25.0%50.0K after |